glutamate drug
Evidence from:
primary |
all sources
Related entities (20)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| acute withdrawal | regulates | glutamate | — | 1 |
| cholinergic agonists | interacts_with | glutamate | — | 1 |
| GLUL | regulates | glutamate | — | 1 |
| glutamate | associated_with | craving | — | 2 |
| glutamate | associated_with | delta rhythm | — | 1 |
| glutamate | associated_with | dorsal raphe nucleus | — | 1 |
| glutamate | interacts_with | EP300 | — | 1 |
| glutamate | associated_with | epilepsy | — | 1 |
| glutamate | regulates | hippocampus | — | 1 |
| glutamate | expressed_in | hippocampus | — | 3 |
| glutamate | risk_factor_for | major depressive disorder | — | 1 |
| glutamate | interacts_with | neuronal excitability | — | 1 |
| glutamate | associated_with | parietal cortex | — | 1 |
| glutamate | risk_factor_for | risk tolerance | — | 1 |
| glutamate | risk_factor_for | schizophrenia | — | 2 |
| glutamate | associated_with | theta oscillations | — | 1 |
| GRIA2 | interacts_with | glutamate | — | 1 |
| GRM8 | regulates | glutamate | — | 1 |
| Slc1a2 | interacts_with | glutamate | — | 2 |
| Slc1a3 | interacts_with | glutamate | — | 1 |
Mentioned in (32)
Papers in which this entity is mentioned.
- Maternal and child immune profiles are associated with neurometabolite measures of early-life neuroinflammation in children who are HIV-exposed and uninfected: a South African birth cohort. (2025)
- Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. (2025)
- Maternal and child immune profiles are associated with neurometabolite measures of early-life neuroinflammation in children who are HIV-exposed and uninfected: a South African birth cohort. (2025)
- Maternal and child immune profiles are associated with neurometabolite measures of early-life neuroinflammation in children who are HIV-exposed and uninfected: a South African birth cohort. (2025)
- Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. (2023)
- H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort study. (2023)
- Embryonic Nicotine Exposure Disrupts Adult Social Behavior and Craniofacial Development in Zebrafish. (2022)
- Large-scale collaboration in ENIGMA-EEG: A perspective on the meta-analytic approach to link neurological and psychiatric liability genes to electrophysiological brain activity. (2021)
- Disruptions in global network segregation and integration in adolescents and young adults with fetal alcohol spectrum disorder. (2021)
- Exposure to ethanol leads to midfacial hypoplasia in a zebrafish model of FASD via indirect interactions with the Shh pathway. (2021)
- Neuroimaging young children and associations with neurocognitive development in a South African birth cohort study. (2020)
- Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome. (2020)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Functional Connectivity and Metabolic Alterations in Medial Prefrontal Cortex in a Rat Model of Fetal Alcohol Spectrum Disorder: A Resting-State Functional Magnetic Resonance Imaging and in vivo Proton Magnetic Resonance Spectroscopy Study. (2019)
- Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. (2019)
- Diving into the world of alcohol teratogenesis: a review of zebrafish models of fetal alcohol spectrum disorder. (2018)
- Executive function and cortical thickness in youths prenatally exposed to cocaine, alcohol and tobacco. (2015)
- Eyeblink Classical Conditioning in Alcoholism and Fetal Alcohol Spectrum Disorders. (2015)
- Position-specific binding of FUS to nascent RNA regulates mRNA length. (2015)
- An in vivo 1H magnetic resonance spectroscopy study of the deep cerebellar nuclei in children with fetal alcohol spectrum disorders. (2014)
- A comparison of spectral quality in magnetic resonance spectroscopy data acquired with and without a novel EPI-navigated PRESS sequence in school-aged children with fetal alcohol spectrum disorders. (2014)
- Properties of MHC class I presented peptides that enhance immunogenicity. (2013)
- Fetal alcohol spectrum disorders: experimental treatments and strategies for intervention. (2011)
- Fetal alcohol spectrum disorders: research challenges and opportunities. (2011)
- Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder. (2011)
- The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats. (2011)
- Focus on: magnetic resonance-based studies of fetal alcohol spectrum disorders in animal models. (2011)
- Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain. (2011)
- Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. (2011)
- Association of single nucleotide polymorphisms in a glutamate receptor gene (GRM8) with theta power of event-related oscillations and alcohol dependence. (2009)
- Chronic binge ethanol-mediated acidemia reduces availability of glutamine and related amino acids in maternal plasma of pregnant sheep. (2008)
- Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. (2007)
Merged raw entities (36)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| glutamate | drug | 200 | 464 |
| synaptic transmission | phenotype | 24 | 30 |
| excitatory synaptic transmission | phenotype | 10 | 14 |
| glutamatergic transmission | phenotype | 10 | 12 |
| neurotransmission | phenotype | 10 | 10 |
| glutamate release | phenotype | 7 | 8 |
| glu | drug | 6 | 21 |
| excitatory transmission | phenotype | 5 | 7 |
| glutamatergic | drug | 5 | 5 |
| glutamatergic activity | phenotype | 5 | 5 |
| glutamatergic neurotransmission | phenotype | 5 | 8 |
| glutamatergic synaptic transmission | phenotype | 5 | 6 |
| inhibitory synaptic transmission | phenotype | 5 | 6 |
| excitatory neurotransmission | phenotype | 4 | 5 |
| glutamatergic neurotransmission | drug | 4 | 4 |
| glutamic acid | drug | 4 | 4 |
| glutamatergic | phenotype | 3 | 4 |
| glutamate transmission | phenotype | 3 | 3 |
| l-glutamate | drug | 2 | 8 |
| extracellular glutamate | drug | 1 | 1 |
| glutamate release | drug | 1 | 1 |
| excitatory glutamatergic transmission | drug | — | — |
| excitatory neurotransmitter | drug | — | — |
| glutamate family | drug | — | — |
| glutamate neurotransmission | drug | — | — |
| glutamate pulses | drug | — | — |
| glutamatergic activity | drug | — | — |
| glutamatergic inhibition | drug | — | — |
| glutamatergic pathway | drug | — | — |
| glutamatergic signal | drug | — | — |
| glutamatergic transmission | drug | — | — |
| glutamate transmission | drug | — | — |
| go:0007268 | drug | — | — |
| go:0035249 | drug | — | — |
| major excitatory neurotransmitter | drug | — | — |
| nmdar-mediated glutamatergic synaptic transmission | drug | — | — |